Cited by 113Lung Cancer Diagnosis and TreatmentGlobal Cancer Incidence and ScreeningHealth disparities and outcomes

Do racial or socioeconomic disparities exist in lung cancer treatment?

Open access
Yang, Relin, Cheung, Michael C., Byrne, Margaret M., Huang, Youjie, Nguyen, Dao, Lally, Brian E., Koniaris, Leonidas G.·2010·Cancer

Abstract

BACKGROUND: Determine the effects of race, socioeconomic status, and treatment on outcomes for patients diagnosed with lung cancer. METHODS: The Florida cancer registry and inpatient and ambulatory data were queried for patients diagnosed from 1998‐2002. RESULTS: A total 76,086 of lung cancer patients were identified. Overall, 55.6% were male and 44.4% were female. The demographic distribution of patients was 92.7% Caucasian, 6.7% African American, and 5.7% Hispanic. The mean age of diagnosis was 70 years old. African American patients presented at a younger age, with more advanced disease, and were less likely to undergo surgical therapy than their Caucasian counterparts. Median survival time (MST) for the entire cohort was 8.7 months, while MST for African American patients was 7.5 months. Patients who received surgery, chemotherapy, or radiation therapy demonstrated significantly improved outcomes. Stepwise multivariate analysis revealed that African American race was no longer a statistically significant predictor of worse outcomes once corrections were made for demographics and comorbid conditions, suggesting that the originally reported disparities in lung cancer outcomes and race may be in part because of poor pretreatment performance status. In contrast, patients of the lowest socioeconomic status continue to have a slightly worse overall prognosis than their affluent counterparts (hazard ratio = 1.05, P = .001). CONCLUSIONS: Lung cancer continues to carry a poor prognosis for all patients. Once comorbidities are corrected for, African American patients carry equivalently poor outcomes. Nonetheless, emphasis must be placed on improving pretreatment performance status among African American patients and efforts for earlier diagnosis among the impoverished patients must be made. Cancer 2010. © 2010 American Cancer Society.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.24986

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Disparities in race, sex, socioeconomic status, level of education, residence, and insurance status, among other factors, continue to be associated with outcomes such as mortality, incidence, stage at diagnosis, and timely receipt of recommended treatment for patients with NSCLC.

    “The results show that disparities in race,128–131 sex,132 socioeconomic status,132–135 level of education,136 residence,128,136 and insurance status,137–139 among other factors, continue to be associated with outcomes such as mortality,128,140 incidence,137,140 stage at diagnosis, and timely receipt of recommended treatment129,131 for patients with NSCLC.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Yang, R., Cheung, M. C., Byrne, M. M., Huang, Y., Nguyen, D., Lally, B. E., & Koniaris, L. G.
Affiliations
  • University of Miami (US)
  • Florida Department of Health (US)
Corresponding author
Koniaris, Leonidas G.
Venue
Cancer
Publisher
Wiley
Published
2010-04-28
Volume
116
Issue
10
Pages
2437-2447
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W2023254395
Cited by
113
References
26
Citations by year
2026: 4 · 2025: 7 · 2024: 5 · 2023: 6 · 2022: 10 · 2021: 5 · 2020: 9 · 2019: 11 · 2018: 5 · 2017: 3 · 2016: 12 · 2015: 8 · 2014: 10 · 2013: 9 · 2012: 2
FWCI
4.79
Type
journal article
Language
en
Open access
Locations
  • Cancer (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
  • Social Sciences › Health › Health disparities and outcomes
Keywords
lung cancer, racial disparities, socioeconomic status, African American patients, survival, surgical treatment, chemotherapy, radiotherapy, performance status, comorbidities, early diagnosis, health disparities
MeSH terms
Aged, Ethnicity, Female, Florida, Humans, Lung Neoplasms, Male, Middle Aged, Poverty, Social Class, Comorbidity, Databases as Topic, Racial Groups, Healthcare Disparities

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review